As standard for initial metastatic screening of PCa, 68Ga‐ or 18F‐radiolabeled‐PSMA‐PET/CT (ie, PSMA‐PET/CT) was recommended by 97% of panelists, followed by wbMRI and bone scan ± SPECT/CT (both 11%) and conventional CT (5%). This evidence concerns the gene FOLH1 and posterior cortical atrophy.